RxDoctor Payments Data

Stephen Schell, MD

Facial Plastic Surgery · Erie, PANPI 1134170939

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $994, 9.8 times the $101 reported in 2019.

$1,857in general payments, 2019–2025

Across 60 payments — averaging $30.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$387
  • Smith+Nephew$253
  • Aerin Medical Inc.$224
  • GSK$222
  • Inspire Medical Systems, Inc.$178
  • Regeneron Healthcare Solutions, Inc.$165
  • plus $428 from 9 others

What the payments were for

  • Food & beverage$1,857100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few facial plastic surgery providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$148,879
Medicare patients
474
Services billed
3,757

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mometasone Furoate123$7,262
Epinephrine28$5,538
Fluticasone Propionate383$3,809
Cephalexin98$1,772
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen63$829
Mupirocin110$716
Omeprazole59$635
Pantoprazole Sodium42$405
Montelukast Sodium59$399
Famotidine34$321
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav44$302
Azelastine Hcl12$236
Meclizine Hcl31$219
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim28$155
Doxycycline Hyclate19$123

Paid to pharmacies, not to this prescriber.

Other facial plastic surgery in Erie

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →